Shashank Patel currently serves as the Associate Vice President of Therapeutics at Immunai, a company whose mission is to decode the immune system to improve human health. Immunai leverages single cell technologies and deep algorithm research to bridge the gap between causal immunology and translational disease biology. At Immunai, the multi-omic knowledge derived from profiling of 50M+ single immune cells from human diseases is informing solutions to the key drug development challenges for pharmaceutical and biopharmaceutical industries. Immunai’s unique technology platform provides unprecedented granular insights in immune dysfunction of myeloid and T cells in cancers that guides the development of novel therapeutics. Before joining Immunai, Patel served as Director of Immunology Research leading discovery and development of immune-oncology medicines at NextCure Inc. Prior to that, he worked with Boehringer Ingelheim as Principal Scientist, and National Institutes of Cancer as Research Scientist. Patel graduated from the National Institutes of Health-Georgetown University Partnership doctoral program in biomedical sciences, and from Oxford University (UK) with a Master of Science in pharmacology and from Middlesex University with an undergraduate degree in biological sciences and information technology.
Disclosure information not submitted.
Cancer Immunity & Immunotherapy Course
Tuesday, June 20, 2023
7:30 AM - 5:45 PM
